BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
172 hedge funds and large institutions have $581M invested in bluebird bio in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 119 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
172
Holders Change
-24
Holders Change %
-12.24%
% of All Funds
2.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
21
Reduced
119
Closed
49
Calls
$4.39M
Puts
$6.11M
Net Calls
-$1.73M
Net Calls Change
+$6.91M
Top Buyers
| 1 |
1
First Trust Advisors
Wheaton,
Illinois
|
$52M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$76.1M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$6.94M |
| 4 |
4
Rafferty Asset Management
New York
|
$5.88M |
| 5 |
5
Citigroup
New York
|
$5.07M |
Top Sellers
| 1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$61.3M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$72.3M |
| 3 |
3
BlackRock
New York
|
$59.1M |
| 4 |
SC
4
Sessa Capital
New York
|
$9.11M |
| 5 |
EC
5
EcoR1 Capital
San Francisco,
California
|
$0 |
